Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05653778 · ClinicalTrials.gov registry record · NA
Scrambler Therapy for Corticobasal Syndrome-Associated Pain
A NA study of Corticobasal Degeneration and Corticobasal Syndrome, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT05653778 is a NA study of Corticobasal Degeneration and Corticobasal Syndrome that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 25 participants, below the 1,985-participant average among 7 other Corticobasal Degeneration trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05653778, a NA study of Corticobasal Degeneration and Corticobasal Syndrome, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot trial is to test whether scrambler therapy (ST) is an effective treatment for neuropathic pain in patients with corticobasal syndrome (CBS). The main question it aims to answer is: Will ST reduce pain scores by at least 33% at one month in this pilot trial, justifying further multi-center trials? Participants will: * be randomly assigned treatment from either transcutaneous electrical nerve stimulation (TENS) or ST for pain initially (eventually all patients will receive ST). * have superficial electrocardiogram (ECG) electrodes placed on the dermatomes involved with pain * obtain treatment lasting 30-40 minutes or until pain relief is obtained Researchers will compare patient's response to pain relief with TENS and ST to determine if ST is an effective treatment for central neuropathic pain.
Conditions Studied
Interventions
- DEVICE Scrambler therapy
- DEVICE TENS treatment
Study Locations (1)
Maryland
- Johns Hopkins School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-04-05 |
| Est. Completion | 2027-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05653778
The ClinicalTrials.gov registry entry for NCT05653778 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,985-participant average among 7 other Corticobasal Degeneration trials with a reported enrollment target (99% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Corticobasal Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Scrambler therapy is the first listed.
NCT05653778 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05653778 about?
NCT05653778 is a clinical study titled "Scrambler Therapy for Corticobasal Syndrome-Associated Pain". The goal of this pilot trial is to test whether scrambler therapy (ST) is an effective treatment for neuropathic pain in patients with corticobasal syndrome (CBS). The main question it aims to answer is: Will ST reduce pain scores by at least 33% at one month in this pilot trial, justifying furthe...
What is the current status of trial NCT05653778?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-04-05. Estimated completion is 2027-02.
What conditions does trial NCT05653778 study?
This clinical trial studies the following conditions: Corticobasal Degeneration, Corticobasal Syndrome, Pain, Neuropathic.
What interventions are being tested in trial NCT05653778?
The interventions under investigation include: Scrambler therapy (DEVICE), TENS treatment (DEVICE).
Who is sponsoring clinical trial NCT05653778?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05653778 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Corticobasal Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Community Outreach for Palliative Engagement -- Parkinson Disease
ACTIVE NOT RECRUITING · NA
-
Gait Analysis in Neurological Disease
RECRUITING
-
NYSCF Scientific Discovery Biobank
RECRUITING
-
The CurePSP Genetics Program
RECRUITING
-
Modifiable Variables in Parkinsonism (MVP)
RECRUITING
-
Imaging Studies in Corticobasal Syndrome
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.